| 1 |
Predictors of Survival Outcomes After Primary Treatment of Epithelial Ovarian Cancer in Lagos, Nigeria |
|
| | Kehinde Sharafadeen Okunade,Adebola A. Adejimi,Ephraim O. Ohazurike,Omolola Salako,Benedetto Osunwusi,Muisi A. Adenekan,Aloy O. Ugwu,Adaiah Soibi-Harry,Olayemi Dawodu,Adeyemi A. Okunowo,Rose I. Anorlu,Jonathan S. Berek | | | JCO Global Oncology. 2021; (7): 89 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
The Challenges of Managing Ovarian Cancer in the Developing World |
|
| | Olivier Mulisya,Franck K. Sikakulya,Mbusa Mastaki,Tambavira Gertrude,Mathe Jeff | | | Case Reports in Oncological Medicine. 2020; 2020: 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Oral etoposide for treatment and/or maintenance treatment of recurrent epithelial ovarian cancer |
|
| | Kehinde Okunade,Adeseye M Akinsete,Omolola Salako,Bosede Bukola Afolabi,Richard D Neal | | | Cochrane Database of Systematic Reviews. 2020; | | | [Pubmed] [Google Scholar] [DOI] | |
|
